These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21718237)

  • 1. Platelet and soluble glycoprotein VI - novel applications in diagnosis and therapy.
    Bigalke B; Elvers M; Schönberger T; Gawaz M
    Curr Drug Targets; 2011 Nov; 12(12):1821-30. PubMed ID: 21718237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome.
    Bigalke B; Stellos K; Stakos D; Joos T; Pötz O; Geisler T; Bischofs C; Kremmer E; Krämer BF; Seizer P; May AE; Lindemann S; Gawaz M
    Thromb Haemost; 2009 May; 101(5):911-5. PubMed ID: 19404545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of glycoprotein VI for theranostics.
    Gawaz M; Vogel S; Pfannenberg C; Pichler B; Langer H; Bigalke B
    Thromb Haemost; 2014 Jul; 112(1):26-31. PubMed ID: 24553806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPVI inhibition: Advancing antithrombotic therapy in cardiovascular disease.
    Slater A; Khattak S; Thomas MR
    Eur Heart J Cardiovasc Pharmacother; 2024 Aug; 10(5):465-473. PubMed ID: 38453424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.
    Jamasbi J; Megens RT; Bianchini M; Münch G; Ungerer M; Faussner A; Sherman S; Walker A; Goyal P; Jung S; Brandl R; Weber C; Lorenz R; Farndale R; Elia N; Siess W
    J Am Coll Cardiol; 2015 Jun; 65(22):2404-15. PubMed ID: 26046734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
    Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets in atherothrombosis--diagnostic and prognostic value of platelet activation in patients with atherosclerotic diseases.
    Bigalke B; Schuster A; Sopova K; Wurster T; Stellos K
    Curr Vasc Pharmacol; 2012 Sep; 10(5):589-96. PubMed ID: 22338574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System.
    Perrella G; Nagy M; Watson SP; Heemskerk JWM
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2681-2692. PubMed ID: 34496636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimeric Glycoprotein VI Binds to Collagen but Not to Fibrin.
    Ebrahim M; Jamasbi J; Adler K; Megens RTA; M'Bengue Y; Blanchet X; Uhland K; Ungerer M; Brandl R; Weber C; Elia N; Lorenz R; Münch G; Siess W
    Thromb Haemost; 2018 Feb; 118(2):351-361. PubMed ID: 29378359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
    Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and therapeutic potentials of platelet glycoprotein VI.
    Bigalke B; Krämer BF; Seizer P; Fateh-Moghadam S; Gawaz M; Lindemann S
    Semin Thromb Hemost; 2010 Mar; 36(2):203-11. PubMed ID: 20414836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring soluble platelet glycoprotein VI in human plasma by ELISA.
    Al-Tamimi M; Mu FT; Moroi M; Gardiner EE; Berndt MC; Andrews RK
    Platelets; 2009 May; 20(3):143-9. PubMed ID: 19437330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet GPVI: a target for antithrombotic therapy?!
    Dütting S; Bender M; Nieswandt B
    Trends Pharmacol Sci; 2012 Nov; 33(11):583-90. PubMed ID: 22901552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of receptor shedding-platelet GPVI as an emerging diagnostic and therapeutic tool.
    Chatterjee M; Gawaz M
    Platelets; 2017 Jun; 28(4):362-371. PubMed ID: 27753514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
    Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
    FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances of Studies on Platelet GPVI as Antithrombotic Target -Review].
    Li P; Qiao JL; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):264-269. PubMed ID: 28245414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity.
    Loyau S; Dumont B; Ollivier V; Boulaftali Y; Feldman L; Ajzenberg N; Jandrot-Perrus M
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):778-85. PubMed ID: 22155453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction.
    Seizer P; Borst O; Langer HF; Bültmann A; Münch G; Herouy Y; Stellos K; Krämer B; Bigalke B; Büchele B; Bachem MG; Vestweber D; Simmet T; Gawaz M; May AE
    Thromb Haemost; 2009 Apr; 101(4):682-6. PubMed ID: 19350111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Patients to Platelets and Back Again: Pharmacological Approaches to Glycoprotein VI, a Thrilling Antithrombotic Target with Minor Bleeding Risks.
    Martins Lima A; Martins Cavaco AC; Fraga-Silva RA; Eble JA; Stergiopulos N
    Thromb Haemost; 2019 Nov; 119(11):1720-1739. PubMed ID: 31564053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A humanized glycoprotein VI (GPVI) mouse model to assess the antithrombotic efficacies of anti-GPVI agents.
    Mangin PH; Tang C; Bourdon C; Loyau S; Freund M; Hechler B; Gachet C; Jandrot-Perrus M
    J Pharmacol Exp Ther; 2012 Apr; 341(1):156-63. PubMed ID: 22238212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.